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ABSTRACT Sphingosine and sphingosine 1-phosphate (S1P) are sphingolipid metabolites that act as signaling messengers to
activate or inhibit multiple downstream targets to regulate cell growth, differentiation, and apoptosis. The amphiphilic nature of
these compounds leads to aggregation above their critical micelle concentrations (CMCs), which may be important for under-
standing lysosomal glycosphingolipid storage disorders.We investigated the aggregation of sphingosine and S1P over a compre-
hensive, physiologically relevant rangeof pH values, ionic strengths, and lipid concentrations bymeans of dynamic light scattering,
titration, and NMR spectroscopy. The results resolve discrepancies in literature reports of CMC and pKa values. At physiological
pH, the nominal CMCs of sphingosine and S1P are 0.995 0.12 mM (pH 7.4) and 14.355 0.08 mM (pH 7.2), respectively. We ﬁnd
that pH strongly affects the aggregation behavior of sphingosine by changing the ionic and hydrogen-bonding states; the nominal
critical aggregation concentrations of protonated and deprotonated sphingosine are 1.715 0.24 mMand 0.705 0.02 mM, respec-
tively. NMR measurements revealed that the NH3
þ–NH2 transition of sphingosine occurs at pH 6.6, and that there is a structural
shift in sphingosine aggregates caused by a transition in the predominant hydrogen-bonding network from intramolecular to inter-
molecular that occurs between pH 6.7 and 9.9.INTRODUCTION
Sphingosine ((2S,3R,4E)-2-amino-4-octadecene-1,3-diol) and
sphingosine 1-phosphate (S1P; (2S,3R,4E)-2-amino-4-octa-
decene-1,3-diol-1-phosphate) are bioactive metabolites that
are produced in the course of sphingolipid turnover induced
by platelet-derived growth factors. S1P is also generated by
de novo biosynthesis at the cytoplasmic face of the endo-
plasmic reticulum (1–5). The biological activities of sphin-
gosine include activation or inhibition of multiple kinases
(6–11), G protein-coupled receptors (12), and channels
(13–15) (see Zheng et al. (16) for review). As a consequence
of these interactions, sphingosine usually has growth-inhib-
itory and apoptotic activities (1,17–19). On the other hand,
S1P is mitogenic and antiapoptotic (1,5,20,21), serving as
both extra- (first) and intracellular (second) messengers to
S1P receptors (3,22). The detailed signaling mechanisms
of these molecules remain unclear, but the opposing func-
tions of sphingosine and S1P have been likened to a ‘‘rheo-
stat’’ that determines cell survival versus death pathways
(21,23). Plasma or serum concentrations of sphingosine
and S1P are maintained by sphingolipid catabolism (1),
and abnormal changes have been implicated in cancer
(3,24) and liver fibrosis (25). An important feature of sphin-
gosine-related molecules (sphingoid bases), which include
sphingosine and S1P, is that they are amphiphilic due to
a hydrophobic alkyl chain and a hydrophilic headgroup
rich in polar groups (OH and NH2). This amphiphilicity
promotes the formation of micellar aggregates above a crit-
ical micelle concentration (CMC). Here we show that these
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tions, which may be important for understanding lysosomal
glycosphingolipid storage disorders. For example, Lloyd-
Evans et al. (26) showed that sphingosine storage is an
initiating factor in neurodegenerative Niemann-Pick type
C1 disease.
Sphingosine is a basic building block of most mammalian
sphingolipids (Fig. 1). In addition to sphingosine, more than
60 different species of sphingoid bases have been reported
(1,27,28). These are distinguished by chain length (14–22
carbon atoms), the number and position of the double bonds,
and the number of hydroxyls (1,16,28). Although different
organisms display considerable variation in sphingoid bases
(27,28), there are usually only a few structural variants in any
one species; for example, humans have primarily sphingo-
sine, sphinganine (dihydrosphingosine), and 4-hydroxy-
sphinganine, plus small amounts of longer-chain-length
homologs (16). Of particular biological interest is S1P,
which is a phosphorylated form of sphingosine (position 1,
Fig. 1) catalyzed by sphingosine kinases (3). The CMC of
S1P has not been reported, and sphingosine’s CMC has
been estimated from fluorescence measurements (29,30)
involving the partitioning of fluorophores into micelles.
The inherent limitation of CMC determinations using fluoro-
phores, such as 8-aminonaphthalene-1,3,6-trisulfonic acid
(ANTS) and 1,6-diphenyl-1,3,5-hexatriene (DPH), are the
assumptions that 1), fluorophore and amphiphile mix ideally;
and 2), the fluorophore does not perturb the CMC. These
problems are likely the cause of the large disparity in sphin-
gosine CMC values reported in the literature (18 mM (30) to
112 mM (29)).
In addition to the range of CMC values reported for sphin-
gosine, there are also inconsistencies in the reported pKa
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titration of sphingosine in Triton X-100 micelles was 6.7
(31). On the other hand, the pKa determined by the pH-depen-
dent change of the gel-to-liquid crystalline phase transition
temperature in a sphingosine/dipalmitoylphosphatidylserine
(DPPS) mixture was found to be 9.1 (32,33). Lo´pez-Garcı´a
et al. (33) pointed out that a possible explanation for these
conflicting pKa values was the difference in hydration level
and hydrogen bonding (both of which shift the pKa of the
amino group) between sphingosines in Triton X-100 micelles
and in bilayers. Because of the biological importance of
sphingoid bases, we systematically examined the aggregation
behavior of sphingosine and S1P using dynamic light scat-
tering, pH titration, and NMR to resolve the disparate values
of CMC and pKa reported in the literature. We discovered in
the course of the measurements that the apparent sphingosine
CMC depends upon pH due to changes in the ionization and
hydrogen-bonding states of sphingosine.
MATERIALS AND METHODS
Materials
Sphingosine (>99%) was a kind gift from Dr. Alfred Merrill (obtained from
Avanti Polar Lipids, Alabaster, AL). S1P was also obtained from Avanti.
Ethanol, triethylamine, and 3-cyclohexylamino-1-propanesulfonic acid
(CAPS) were purchased from Acros Organics (Geel, Belgium). Dulbecco’s
PBS (DPBS) buffer without Ca2þ and Mg2þ was purchased from HyClone
(Logan, UT). n-Dodecyl b-D-maltoside, 2-(N-morpholino)ethanesulfonic
acid (MES), and sodium azide were obtained from Sigma Chemical Co.
(St. Louis, MO), and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) was purchased from Fisher Scientific (Pittsburgh, PA). Glycine
was purchased from Mallinckrodt Baker (Phillipsburg, NJ). Deuterium
oxide (D2O), sodium deuteroxide (NaOD) and deuterium chloride (DCl)
were purchased from Cambridge Isotope Laboratories (Andover, MA). All
chemicals were used as purchased without further purification.
FIGURE 1 Chemical structures of sphingosine and S1P. Both molecules
are bioactive metabolites produced in the course of an agonist-induced
sphingolipid turnover and de novo biosynthesis.Biophysical Journal 96(7) 2727–2733Sample preparation
For dynamic light scattering experiments, various concentrations of sphin-
gosine and S1P were prepared by mixing stock solution with buffer. The
stock solution of sphingosine (10 mM) was prepared by diluting sphingosine
with ethanol. Because the solubility of S1P in organic solvent is quite low,
we used a modified version of the procedure described on Avanti’s web site
(http://www.avantilipids.com/SyntheticSphingosine-1-phosphate.asp): S1P
was solubilized with methanol-triethylamine (20:3 v/v) to prepare 14 mM
stock solution of S1P. The buffers used for the light scattering experiments
with sphingosine were composed of 10 mM HEPES, 2 mM MES, 2 mM
glycine, 10 mM CAPS, 140 mM NaCl, and 3 mM sodium azide. The buffer
for the light scattering studies of S1P was DPBS.
For pH titration experiments, sphingosine stock solution (10 mM) was
mixed with 0.25 mM HCl(aq) containing 140 mM NaCl. The initial concen-
tration of sphingosine was 200 mM.
For NMR measurements, appropriate amounts of sphingosine (powder)
and NaCl were suspended with D2O (1 mL) to replace exchangeable protons
of sphingosine with deuterium. Because several sphingosine signals resonate
near the strong hydrogen deuterium oxide signal, the samples were exchanged
into D2O a second time. After the samples were vortexed to achieve a homo-
geneous dispersion, they were lyophilized and resuspended with D2O or
20 mM dodecyl maltoside in D2O (500 mL) to the desired concentrations.
The pH values of the samples were adjusted by adding NaOD or DCl in D2O.
Dynamic light scattering measurements
Dynamic light scattering measurements were performed on a DAWN
HELEOS (Wyatt, Santa Barbara, CA; laser wave length: 658 nm) using
the same procedure as described in a previous study (34). In brief, the
measured intensity of scattered light from each sample was normalized to
that of the buffer. The polydispersity parameter (m2) and averaged hydrody-
namic radius (Rh) were determined from the intensity-intensity correlation
function using the cumulants method (35,36). The accuracy of determina-
tions of Rh was checked by means of control experiments using bovine
serum albumin, whose Rh is well known.
pH titration experiments
pH titration experiments were performed by adding NaOH(aq) (with
140 mM NaCl, pH 11) to sphingosine solution at room temperature.
NMR measurements
1H NMR and 1H-13C heteronuclear multiple-quantum coherence (HMQC)
measurements were performed at 35C on an INOVA 800 MHz NMR
spectrometer (Varian, Palo Alto, CA) equipped with a triple-axis gradient
triple-resonance (1H13C15N) 5-mm probe. Nonspinning spectra were
collected with a recycle delay of 2 s. Water suppression was achieved using
WATERGATE (37). 1H NMR spectra were collected with 16,384 complex
points, 128 scans, and a spectral width of 10,000 Hz. Natural-abundance
1H-13C HMQC spectra were collected with 4096 points for proton, 128
increments for carbon, and 256 scans. Chemical shifts were referenced to
2,2-dimethyl-2-silapentane-5-sulfonic acid. Data were processed with
NMRPipe (38) using a polynomial filter for solvent elimination. Observation
of the signal/noise (S/N) ratio (measured with respect to baseline) of the NMR
signal provided information on aggregation, because line widths correlate
with the size of aggregates. After excitation, larger aggregates with slower
thermal motion undergo faster relaxation, mainly via the spin-spin (T2) relax-
ation pathway, which broadens the signal line width. In the extreme case of
very large aggregates, lines become so broad that they are undetectable.
RESULTS
The aggregation behavior of sphingosine and S1P over
a comprehensive range of physiological pH values and lipid
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FIGURE 2 Aggregation behaviors of sphingosine and S1P at various pH
values. (A) Change in m2 values at 25
C of sphingosine and S1P. The data
for sphingosine at pH 3.6, 7.4, and 9.9 are depicted by open circles, solid
circles, and open squares, respectively. The data for S1P at pH 7.2 are
represented by solid squares. Aggregation is indicated by the decrease in
the polydispersity parameter (m2) (34,39). These data suggest that pH has
a strong effect on the aggregation behavior of sphingosine, and that the
concentrations at which half-aggregations occur (C50) are 1.71  0.24 mM
(pH 3.6), 0.99  0.12 mM (pH 7.4), and 0.70  0.02 mM (pH 9.9). These
data also demonstrate that the attachment of a phosphate group to sphingo-
sine increases the solubility of S1P. The C50 at physiological pH (7.2) of S1P
(14.35  0.08 mM) was 14-fold higher than that of sphingosine. (B) Rh of
sphingosine in buffers (pH 3.6, 7.4, and 9.9) at different concentrations at
25C. The data for pH 3.6, 7.4 and 9.9 are depicted by open circles, solid
circles, and open squares, respectively. The inset shows the small, but
nonzero, values of Rh at concentrations below the CMC. These data show
that the sphingosine aggregates formed at pH 9.9 are larger than those
formed at pH 3.6 or 7.4, and continued to increase in size depending on
the concentration between 0.5 mM and 10 mM. Compared with panel A,
the aggregation ranges at both pH values revealed by the changes in Rh
were consistent with those shown by m2.concentrations were analyzed by dynamic light scattering
using the cumulants method (Fig. 2), which provides the
hydrodynamic radius (Rh) and a parameter (m2) that corre-
lates with the polydispersity of the solution (the higher
the m2, the higher the polydispersity). The m2 of transitional
phases comprised of coexisting monomers and aggregates is
much higher than that of an aggregated phase in which
aggregates predominate. Hence, aggregation can be detected
by an increase in the hydrodynamic radius and a decrease in
the polydispersity parameter (34,39). At neutral pH, the
concentrations at which half-aggregation of sphingosine or
S1P occur (C50, defined as the CMC) were determined to
be 0.99  0.12 mM (pH 7.4) and 14.35  0.08 mM
(pH 7.2), respectively (Fig. 2 A).
pH affects the ionic state of sphingosine and consequently
its aggregation. The main objective of this study was to
clarify the pH dependence of sphingosine aggregation. Our
first step was to examine aggregation under conditions in
which we could be reasonably sure of the sphingosine’s ionic
state. The reported pKa values of sphingosine are 6.7 and 9.1
(31–33). If the NH3
þ–NH2 transition occurs at pH 6.7 (31),
the predominant ionic state of sphingosine should be the
neutral form above pH 6.7, implying that the CMC should
be approximately constant between pH 6.7 and pH 9.1. On
the other hand, if the NH3
þ–NH2 transition occurs at
pH 9.1 (32,33), the predominant ionic form should be the
charged form below pH 9.1. In that case, raising the pH
above 9.1 should neutralize the NH3
þ, lower the solubility
of sphingosine, and consequently decrease the CMC. Our
data show, however, that the CMC did not decrease signifi-
cantly when the pH was raised from 7.4 to 9.9. The C50 at
pH 9.9 was 0.70  0.02 mM (Fig. 2 A), about the same as
at pH 7.4. Unlike at pH 7.4, however, the CMC transition
occurs over a wider concentration range, suggesting a new
physical behavior. This is emphasized by Fig. 2 B, which
shows that the mean micelle radius at pH 9.9 is larger than
those at pH 3.6 or 7.4. Furthermore, Rh continues to increase
as the concentration rises from 0.5 to 10 mM.
These results suggest a more complex aggregation
behavior than expected. Specifically, the continued addition
of sphingosine resulted in growth of the aggregate size rather
than the numbers of fixed-size aggregates. We then measured
C50 and Rh at pH 3.6 to ensure full ionization of the sphingo-
sine amine group. We found that C50¼ 1.71 0.24 mM, and
that the m2 for aggregates was 10
7 s2 (Fig. 2 A), which is
significantly larger than the values (~105 s2) observed at
pH 7.4 and 9.9. The mean micelle radius at pH 3.6 was
~50 nm (Fig. 2 B).
The previously reported pKa of sphingosine was obtained
in the presence of Triton X-100 (31) or DPPS (33). To clarify
further the pH-dependent aggregation of sphingosine, we
determined directly, by simple pH titrations, the pKa of
sphingosine in buffer in the absence of detergent or other
lipids (Fig. 3). The experiments were necessarily performed
at a high sphingosine concentration at which sphingosineBiophysical Journal 96(7) 2727–2733
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0.03, and did not change as a function of salt concentration
(3 mM to 1 M; data not shown). The pKa of monomeric
sphingosine could not be determined because the buffering
capacity of monomeric sphingosine is too small at very
low concentrations (<0.5 mM; data not shown).
Our titration and CMC data suggested a significant
structural rearrangement of sphingosine aggregates under
basic conditions. We therefore carried out an NMR structural
analysis of sphingosine. Despite the aggregation, the S/N
ratio of the NMR spectrum (see Materials and Methods) at
pH 6.7 was quite high (Fig. 4 A). All peaks were assigned
by means of the 1H-13C HMQC experiment. Fig. 4 B shows
1H NMR spectra of aggregated sphingosine at three different
pH values: pH 2.0< pKa, pH 6.7z pKa, and pH 10.6> pKa
(shown in spectra a–c, respectively, of Fig. 4 B). A compar-
ison of the spectra in panels a and b reveals that the ionic
environment changed at the pKa, causing a shift of the
aliphatic proton peaks located at positions 1–3 (H1–3;
Fig. 1) without significant changes in the other peaks
(Fig. 4 B and Table 1).
The spectra collected at pH 10.6 (Fig. 4 B, spectrum c)
revealed broadening of all sphingosine signals to the point
of being undetectable. This was reversed when the pH was
lowered to pH 6.7. The S/N ratio difference between
pH 6.7 and 10.6 is consistent with the change in aggregate
size in this pH range detected by light scattering (Fig. 2 B).
Merrill et al. (31) suggested that intramolecular hydrogen
bonds are an important feature of sphingosine at acidic pH,
because sphingosine contains both a donor and acceptor of
FIGURE 3 The pH titration curve of sphingosine. The initial concentra-
tion of sphingosine was 200 mM. The concentration of sphingosine
decreased along with the increase in volume (up to 1.7-fold) during titration,
but sphingosine exists as aggregates over the entire pH range (see Fig. 2 A).
The NaCl concentration was constant at 140 mM during titration. The pKa
of aggregated sphingosine was determined to be 6.61  0.03.Biophysical Journal 96(7) 2727–2733hydrogen bonds. This characteristic structure is conserved
in all sphingolipids. At basic pH values, this intramolecular
hydrogen bonding should be reduced, possibly leading to
predominant intermolecular hydrogen bonding between
monomers and the stabilization of larger aggregates.
To assess the effect of intermolecular hydrogen bonding
on aggregate size, experiments were carried out using sphin-
gosine dispersed with dodecyl maltoside to disrupt possible
intermolecular hydrogen bonding at all pH values. Ignoring
the dodecyl maltoside peaks, Fig. 4 C shows that the spectra
of sphingosine dispersed in the detergent are identical at pH
7 (Fig. 4 C, spectrum b) and pH 12 (Fig. 4 C, spectrum c),
and that both are identical to the spectrum of aggregated
sphingosine at pH 6.7 (Fig. 4 C, spectrum a). In contrast
to the NMR data in bulk water (Fig. 4 B), in the presence
of dodecyl maltoside micelles, the pH change from 7 to 12
induced no significant change in the S/N ratio or in the
chemical shifts of the peaks that correspond to H1–3 of
sphingosine (Fig. 4 C). These results support the idea that
intermolecular hydrogen bonding is crucial for the growth
of aggregate size (Fig. 2 B, pH 9.9).
DISCUSSION
We used dynamic light scattering measurements (Fig. 2) to
determine the aggregation behavior of sphingosine and S1P.
This approach avoids the artifacts that might accompany
indirect fluorescence measurements based on fluorophore
partitioning (29,30). The measurements reveal a somewhat
complex dependence of aggregation on pH. This is important
because cells are not composed of organelles that have
a uniform neutral pH. For example, lysosomes and endo-
somes have acidic pH and play important roles in sphingolipid
catabolism; endocytic vesicles of sphingolipids are sorted in
early endosomes and recycled back to the plasma membrane
or transported to lysosomes, where they are degraded into
sphingoid bases like sphingosine (1,16).
Fig. 2 A presents what we believe to be the first report of
the CMC of S1P at physiological pH. The C50 of S1P,
14.35 mM, is 14-fold higher than that of sphingosine due
to the attachment of phosphoryl group to the position 1 of
sphingosine (Fig. 1). This may explain why S1P can serve
as an effective extracellular (first) messenger, because the
concentration of S1P in blood (0.1–1 mM (16)) is lower
than the C50, meaning that S1P can exist as monomers in
the bloodstream.
The situation for sphingosine is more complex. The pKa of
sphingosine (6.61) as determined here by simple pH titration
of aggregates is consistent with the value reported for Triton
X-100 micelles (31). Consequently, the hypothesis that
sphingosine has a net positive charge at neutral pH (1,32)
is not correct for sphingosine aggregates. Approximately
86% of sphingosine molecules are in the electrically neutral
(deprotonated) form in aggregates at the physiological
pH of 7.4. The total concentration of sphingosine in cells
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FIGURE 4 pH-dependent changes of sphingosine aggregates in bulk
buffer, and mixed micelles with dodecyl maltoside. (A) 1H NMR spectrum
of aggregated sphingosine (12 mM) in D2O with 26 mM NaCl (pH 6.7) at
35C. Signals were assigned as denoted using the results of the
1H-13C HMQC experiment. (B) 1H NMR spectra of aggregated sphingosine
(24 mM) at different pH values in D2O with 26 mM NaCl at 35
C. The
spectra collected at pH 2.0 (< pKa), 6.7 (~pKa), and 10.6 (>pKa) are shown
as a, b, and c, respectively. The inset shows the magnified spectra at pH 2.0
and 6.7 around the peak of methine proton located at position 3 in Fig. 1
(H3). Spectra a and b suggest that the pH change around pKa influences
the chemical shifts of the peaks that correspond to H1–3, whereas those
of other peaks do not change significantly. This spectral change indicatesis probably in the range of 0.1–1.0 mM (16), but the unbound
concentration of sphingosine is uncertain. This range corre-
sponds roughly to the range over which sphingosine aggre-
gates in our experiment. The critical question, which cannot
be answered at this time, is whether sphingosine’s free
energy is lower in aggregates or partitioned into other
membrane components like lipoproteins. Nevertheless,
understanding the aggregation of sphingosine in vitro
provides a reference point for explorations of aggregation
in vivo.
Fig. 2 B reveals that the ratio between aggregate and mono-
mer can change dramatically in the submicromolar concentra-
tion range. Our finding that most sphingosine molecules in
aggregates are electrically neutral at physiological pH may
explain why sphingoid bases can readily move among
membranes and across bilayers (1), unless transmembrane
movement is impeded by acidic pH, such as in lysosomes
(pH < 5.2). At pH values of 3.6 and 9.9, the protonated frac-
tions of sphingosine are 99.9% and 0.1%, respectively.
Hence, the aggregation curves at pH 3.6 and 9.9 can be taken
as those for protonated and deprotonated sphingosine, respec-
tively. Protonated sphingosine has a 2.4-fold higher C50 than
deprotonated sphingosine. Furthermore, the m2 of the aggre-
gates composed of protonated sphingosine is higher than
that of deprotonated sphingosine aggregates, which reflects
the poor stability of protonated sphingosine aggregates due
to the Coulombic repulsion of charged sphingosine.
The structure of the aggregates depends critically on pH
values in the neighborhood of pH 7, as shown in Fig. 2 B. If
the sphingosine is completely deprotonated, increases in
sphingosine concentration will lead to unrestrained growth
in aggregate size (pH 9.9 curve). Small amounts of protonated
sphingosine, however, restrict the growth of aggregate size
and cause reversion to a CMC-like behavior (pH 6.7 and
pH 7.4 curves) in which increases in concentration increase
the concentration rather than the size of the aggregates.
NMR data provided structural insights into the pH-depen-
dent change of sphingosine as detected by light scattering
that the NH3
þ–NH2 transition occurs on sphingosine at pKa. Notably, spec-
trum c is completely different from spectra a and b, and is missing sphingo-
sine peaks. The scale for spectrum c was increased fivefold compared to
spectra a and b to visualize peaks that may be in the baseline. The sharp
singlet signals at 1.15, 1.30, 1.95, and 3.75 ppm in spectrum c are from
a trace amount of contaminants. This suggests that a global change in the
organization of aggregates occurs between pH 6.7 and 10.6. (C) 1H-13C
HMQC spectra of sphingosine (12 mM) in D2O with 26 mM NaCl
(pH 6.7) at 35C (a), and sphingosine (2 mM) in the presence of dodecyl
maltoside micelles (20 mM) at pH 7 (b) and 12 (c) in D2O with 25 mM
NaCl at 35C. The circles show the signals that originated from sphingosine,
and the letters refer to the assignment of each signal. Other signals shown in
spectra b and c are from dodecyl maltoside. These data show that, in the
presence of dodecyl maltoside micelles, a pH change between pH 7 and
12 induces no significant change in the S/N ratio or in the chemical shifts
of the peaks that correspond to H1–3. This suggests that the sphingosine
molecules that are surrounded by the detergent molecules in micelles do
not undergo morphological changes in this pH range.Biophysical Journal 96(7) 2727–2733
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þ–NH2 transition,
deprotonation of cationic NH3
þ to neutral NH2 increases the
electron densities of the atoms adjacent to the amine moiety,
which causes an upfield shift in the NMR signals from those
atoms (Fig. 4). Our finding that the upfield shifts were exclu-
sively observed in the NMR peaks from H1–3 accompa-
nying the pH increase (Fig. 4 B, spectra a and b; Table 1),
supports the idea that the NH3
þ–NH2 transition occurs in
TABLE 1 1H chemical shifts (d) of the NMR peaks from H1–3
in aggregated sphingosine (24 mM) at different pH values
pH d H1 d H2 d H3
2.0 3.78, 3.85 3.49 4.53
6.7 3.61, 3.71 3.00 4.21
H1–3 are the protons at positions 1–3 of sphingosine, which is adjacent to
amine group at position 2. pH values of 2.0 and 6.7 are below and slightly
above the pKa (6.6) of sphingosine, respectively (Fig. 3).
OHOH
NH3+
OHOH
NH2
OHOH
NH2
OHOH
NH2
OHOH
NH2
A
B
C
FIGURE 5 Predominant molecular states of aggregated sphingosine at
different pH values suggested by the data shown in this study. (A) At pH
below pKa (6.6), NH2 moiety of sphingosine is protonated. At pH slightly
above pKa, sphingosine exists as an electrically neutral molecule with
a deprotonated amine group. (B) As reported by Merrill et al. (31), intramo-
lecular hydrogen bonds are formed between OH and NH2 groups of sphin-
gosine (broken lines). (C) Between pH 6.7 and 9.9, intermolecular hydrogen
bonding becomes predominant (broken lines); such bonds are efficiently
formed only when sphingosine molecules exist in close proximity, which
increases the mean aggregate radius.Biophysical Journal 96(7) 2727–2733aggregated sphingosine at pH ¼ pKa, because sphingosine
has an amine group at position 2 (Fig. 1). The line widths
in NMR spectra of aggregates are strongly influenced by
the particle size: slower thermal motion of larger aggregates
leads to faster relaxation predominantly in the T2 relaxation
pathway and, consequently, a smaller S/N ratio. The larger
aggregate size at pH 9.9 compared to pH 7.4 (Fig. 2 B)
supports the considerable decrease in S/N ratio induced by
the pH increase from 6.7 to 10.6 (Fig. 4 B, spectra b and c).
Sphingosine can form an intramolecular hydrogen-
bonding network (Fig. 5 B) (31), because it contains both
a donor and acceptor of hydrogen bonds. Because this charac-
teristic structure is conserved in all sphingolipids, we expect
that sphingosine should also form intermolecular hydrogen
bonds under the right circumstances, namely deprotonation
of the amine group. Our data suggest that the most plausible
explanation for the changes in the aggregation structure of
sphingosine between pH 6.7 and 9.9 is a shift in the predom-
inant hydrogen-bonding network from intramolecular to
intermolecular (Fig. 5 C). This shift must play a key role in
the formation of larger sphingosine aggregates. The finding
that sphingosine surrounded by dodecyl maltoside in micelles
does not demonstrate a spectral change between pH 7 and 12
(Fig. 4C) supports this idea, because intermolecular hydrogen
bonds are formed efficiently only when sphingosine mole-
cules exist as near neighbors. This novel aggregation behavior
suggests that the pKa value of 9.1 reported in a previous differ-
ential scanning calorimetry study (33) reflects the structural
transition of sphingosine from an intramolecular to an inter-
molecular hydrogen-bonding network, because differential
scanning calorimetry is sensitive to the morphological
changes in aggregates rather than to direct changes in ionic
state.
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